Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0032285 (
pneumonia
)
54,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study aimed to identify the potential key genes associated with severe
pneumonia
using mRNA-seq. Nine peripheral blood samples from patients with severe
pneumonia
alone (SP group, n=3) and severe
pneumonia
accompanied with chronic obstructive pulmonary disease (COPD; CSP group, n=3), as well as volunteers without
pneumonia
(control group, n=3) underwent mRNA-seq. Based on the sequencing data, differentially expressed genes (DEGs) were identified by Limma package. Following the pathway enrichment analysis of DEGs, the genes that were differentially expressed in the SP and CSP groups were selected for pathway enrichment analysis and coexpression analysis. In addition, potential genes related to
pneumonia
were identified based on the information in the Comparative Toxicogenomics Database. In total, 645 and 528 DEGs were identified in the SP and CSP groups, respectively, compared with the normal controls. Among these DEGs, 88 upregulated genes and 80 downregulated genes were common between the two groups. The functions of the common DEGs were similar to those of the DEGs in the SP group. In the coexpression network, the commonly downregulated genes (including
ND1, ND3, ND4L
, and
ND6
) and the commonly upregulated genes (including
TSPY6P
and
CDY10P
) exhibited a higher degree. In addition, 131 DEGs (including
ND1, ND3, ND6, MIR449A
and
TAS2R43
) were predicted to be potential
pneumonia
-related genes. In conclusion, the present study demonstrated that the common DEGs may be associated with the progression of severe
pneumonia
.
...
PMID:Identification of potential key genes associated with severe pneumonia using mRNA-seq. 3011 34